<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cdg-1a" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cdg-1a</book-part-id>
      <title-group>
        <title>PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>)</title>
        <alt-title alt-title-type="alt-title">Synonyms: CDG1a, Congenital Disorder of Glycosylation Type 1a, Phosphomannomutase 2 Deficiency</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sparks</surname>
            <given-names>Susan E</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Sanofi Genzyme<break/>Cambridge, Massachusetts</aff>
          <email>susan.sparks@genzyme.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Krasnewich</surname>
            <given-names>Donna M</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>dkras@mail.nih.gov</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>15</day>
          <month>8</month>
          <year>2005</year>
        </date>
        <date date-type="updated">
          <day>29</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="pmd" document-type="chapter">
<italic toggle="yes">PLP1</italic>-Related Disorders</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="pnpla6-dis" document-type="chapter"><italic toggle="yes">PNPLA6-</italic>Related Disorders</related-object>
      <abstract id="cdg-1a.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) (previously known as congenital disorder of glycosylation type 1a), the most common of a group of disorders of abnormal glycosylation of N-linked oligosaccharides, is divided into three types: infantile multisystem, late-infantile and childhood ataxia-intellectual disability, and adult stable disability. The three types notwithstanding, clinical presentation and course are highly variable, ranging from infants who die in the first year of life to mildly involved adults. Clinical presentations tend to be similar in sibs.</p>
          <list list-type="bullet">
            <list-item>
              <p>In the infantile multisystem type, infants show axial hypotonia, hyporeflexia, esotropia, and developmental delay. Feeding problems, vomiting, failure to thrive, and impaired growth are frequently seen. Subcutaneous fat may be excessive over the buttocks and suprapubic region. Two distinct clinical presentations are observed: (1) a non-fatal neurologic form with strabismus, psychomotor retardation, and cerebellar hypoplasia in infancy followed by neuropathy and retinitis pigmentosa in the first or second decade and (2) a neurologic-multivisceral form with approximately 20% mortality in the first year of life.</p>
            </list-item>
            <list-item>
              <p>The late-infantile and childhood ataxia-intellectual disability type, with onset between age three and ten years, is characterized by hypotonia, ataxia, severely delayed language and motor development, inability to walk, and IQ of 40 to 70; other findings include seizures, stroke-like episodes or transient unilateral loss of function, retinitis pigmentosa, joint contractures, and skeletal deformities.</p>
            </list-item>
            <list-item>
              <p>In the adult stable disability type, intellectual ability is stable; peripheral neuropathy is variable, thoracic and spinal deformities progress, and premature aging is observed; females lack secondary sexual development and males may exhibit decreased testicular volume. Hyperglycemia-induced growth hormone release, hyperprolactinemia, insulin resistance, and coagulopathy may occur. An increased risk for deep venous thrombosis is present.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) is established in a proband with type I transferrin isoform pattern and either identification of biallelic pathogenic variants in <italic toggle="yes">PMM2</italic> on molecular genetic testing or low levels of phosphomannomutase (PMM) enzyme activity if results of molecular genetic testing are uncertain.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Maximal caloric intake including use of a nasogastric tube or gastrostomy tube; anti-gastroesophageal reflux measures; occupational therapy, physical therapy, and speech therapy for developmental delay; hydration and physical therapy for stroke-like episodes; orthopedic intervention for scoliosis; rehabilitation medicine services including wheelchairs, transfer devices, and physical therapy as needed.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Attention to coagulation status before surgery because of increased risk of bleeding and/or deep venous thrombosis. Education about risks and symptoms of deep venous thrombosis.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Cautious use of acetaminophen and other agents metabolized by the liver.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) is inherited in an autosomal recessive manner. At conception, the theoretic risks to sibs of an affected individual are a 25% risk of being affected, a 50% risk of being an asymptomatic carrier, and a 25% risk of being unaffected and not a carrier; however, based on outcomes of at-risk pregnancies, the risk of having an affected child is closer to 1/3 than to the expected 1/4. Carrier testing for at-risk family members and prenatal diagnosis for pregnancies at increased risk are possible if both <italic toggle="yes">PMM2</italic> pathogenic variants in the family have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cdg-1a.Diagnosis">
        <title>Diagnosis</title>
        <p>PMM2-CDG (CDG-Ia) is the most common of a group of disorders of abnormal glycosylation of N-linked oligosaccharides.</p>
        <sec id="cdg-1a.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) <bold>should be suspected</bold> in a <bold>child</bold>, <bold>adolescent or adult</bold>, or <bold>fetus</bold> with the following findings.</p>
          <sec id="cdg-1a.In_a_Child">
            <title>In a Child</title>
            <p>In a child with developmental delay and hypotonia in combination with any of the following clinical and laboratory findings:</p>
            <list list-type="bullet">
              <list-item>
                <p>
                  <bold>Clinical findings</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Failure to thrive</p>
                  </list-item>
                  <list-item>
                    <p>Hypothyroidism, hypogonadism</p>
                  </list-item>
                  <list-item>
                    <p>Esotropia</p>
                  </list-item>
                  <list-item>
                    <p>Pericardial effusion</p>
                  </list-item>
                  <list-item>
                    <p>Abnormal subcutaneous fat pattern including increased suprapubic fat pad, skin dimpling, and inverted nipples or subcutaneous fat pads having a toughened, puffy, or uneven consistency</p>
                  </list-item>
                  <list-item>
                    <p>Seizures</p>
                  </list-item>
                  <list-item>
                    <p>Stroke-like episodes</p>
                  </list-item>
                  <list-item>
                    <p>Osteopenia, scoliosis</p>
                  </list-item>
                  <list-item>
                    <p>Cerebellar hypoplasia/atrophy and small brain stem [<xref ref-type="bibr" rid="cdg-1a.REF.aronica.2005.433">Aronica et al 2005</xref>] and characteristic findings on brain MRI (see <xref ref-type="sec" rid="cdg-1a.Clinical_Description">Clinical Description</xref>)</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>
                  <bold>Laboratory findings</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Hepatic dysfunction (elevated transaminases)</p>
                  </list-item>
                  <list-item>
                    <p>Coagulopathy with low serum concentration of factors IX and XI, antithrombin III, protein C, and/or protein S</p>
                  </list-item>
                  <list-item>
                    <p>Type I transferrin isoform pattern on analysis of serum transferrin glycoforms (also called "transferrin isoforms analysis" or "carbohydrate-deficient transferrin analysis"). The analysis, based on isoform analysis (by isoelectric focusing (IEF) or other methods (capillary electrophoresis, GC/MS, CE-ESI-MS, MALDI-MS), determines the number of sialylated N-linked oligosaccharide residues linked to serum transferrin [<xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.811">Jaeken &#x00026; Carchon 2001</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.marklov_.2007.6">Marklov&#x000e1; &#x00026; Albahri 2007</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.sanznebot.2007.1949">Sanz-Nebot et al 2007</xref>].</p>
                    <p>Results of such testing may reveal the following:</p>
                    <list list-type="bullet">
                      <list-item>
                        <p><bold>Normal transferrin isoform pattern.</bold> Two biantennary glycans linked to asparagine with four sialic acid residues</p>
                      </list-item>
                      <list-item>
                        <p><bold>Type I transferrin isoform pattern.</bold> Decreased tetrasialotransferrin and increased asialotransferrin and disialotransferrin. The pattern indicates defects in the earliest synthetic steps of the N-linked oligosaccharide synthetic pathway.</p>
                      </list-item>
                      <list-item>
                        <p><bold>Type II transferrin isoform pattern.</bold> Increased trisialotransferrins and/or monosialotransferrins. The pattern indicates defects in the later parts of the N-linked glycan pathway.</p>
                      </list-item>
                    </list>
                    <p>Note: (1) The diagnostic validity of analysis of serum transferrin glycoforms before age three weeks is controversial [<xref ref-type="bibr" rid="cdg-1a.REF.clayton.1992.857">Clayton et al 1992</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.stibler.1994.71">Stibler &#x00026; Skovby 1994</xref>]. (2)The use of Guthrie cards with whole blood samples is not suggested; however, the use of Guthrie cards with blotted serum yields accurate results [<xref ref-type="bibr" rid="cdg-1a.REF.carchon.2006.774">Carchon et al 2006</xref>]. (3) Individuals with the clinical diagnosis of PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) and biochemical diagnosis of PMM enzyme deficiency with normal transferrin glycosylation have been reported [<xref ref-type="bibr" rid="cdg-1a.REF.fletcher.2000.396">Fletcher et al 2000</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.marquardt.2003.359">Marquardt &#x00026; Denecke 2003</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.hahn.2006.235">Hahn et al 2006</xref>]. (4) The possibility that an abnormal transferrin glycoform analysis is the result of a transferrin protein variant can be confirmed with a glycoform analysis of a serum sample from the parents or by a neuraminidase treatment followed by IEF and ESI-TOF MS [<xref ref-type="bibr" rid="cdg-1a.REF.park.2014.135">Park et al 2014</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.z_hlsdorf.2015.11">Z&#x000fc;hlsdorf et al 2015</xref>]. (5) In adults with milder forms of PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>), serum transferrin glycoforms can be mildly abnormal or near normal [<xref ref-type="bibr" rid="cdg-1a.REF.wolthuis.2014.217">Wolthuis et al 2014</xref>].</p>
                  </list-item>
                </list>
              </list-item>
            </list>
          </sec>
          <sec id="cdg-1a.In_an_Adolescent_or_Adult">
            <title>In an Adolescent or Adult</title>
            <p>An adolescent or adult with any of the following clinical and laboratory findings:</p>
            <list list-type="bullet">
              <list-item>
                <p>
                  <bold>Clinical findings</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Cerebellar dysfunction (ataxia, dysarthria, dysmetria) and characteristic findings on brain MRI (see <xref ref-type="sec" rid="cdg-1a.Clinical_Description">Clinical Description</xref>)</p>
                  </list-item>
                  <list-item>
                    <p>Non-progressive cognitive impairment</p>
                  </list-item>
                  <list-item>
                    <p>Seizures</p>
                  </list-item>
                  <list-item>
                    <p>Stroke-like episodes</p>
                  </list-item>
                  <list-item>
                    <p>Peripheral neuropathy with or without muscle wasting</p>
                  </list-item>
                  <list-item>
                    <p>Absent puberty in females, small testes in males</p>
                  </list-item>
                  <list-item>
                    <p>Retinitis pigmentosa</p>
                  </list-item>
                  <list-item>
                    <p>Progressive scoliosis with truncal shortening</p>
                  </list-item>
                  <list-item>
                    <p>Joint contractures</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>Laboratory findings.</bold> Type I transferrin isoform pattern on analysis of serum transferrin glycoforms (see <xref ref-type="sec" rid="cdg-1a.In_a_Child">In a Child</xref>, <bold>Laboratory findings</bold>, Type I transferrin isoform pattern)</p>
              </list-item>
            </list>
          </sec>
          <sec id="cdg-1a.In_a_Fetus">
            <title>In a Fetus</title>
            <p>A fetus with non-immune hydrops fetalis [<xref ref-type="bibr" rid="cdg-1a.REF.van_de_kamp.2007.277">van de Kamp et al 2007</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.l_tic_e.2010.253">L&#x000e9;tic&#x000e9;e et al 2010</xref>]</p>
          </sec>
        </sec>
        <sec id="cdg-1a.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of PMM2-CDG (<italic toggle="yes">CDG-Ia)</italic>
<bold>is established</bold> in a proband with type I transferrin isoform pattern and identification of either biallelic pathogenic variants in <italic toggle="yes">PMM2</italic> on molecular genetic testing (see <xref ref-type="table" rid="cdg-1a.T.summary_of_molecular_genetic_te">Table 1</xref>) or low levels of phosphomannomutase (PMM) enzyme activity if results of molecular genetic testing are uncertain.</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, a <bold>multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">PMM2</italic> is performed first followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
              <p>Note: Three pathogenic variants are common in individuals of European ancestry and may be included on carrier screening panels:</p>
              <list list-type="bullet">
                <list-item>
                  <p>The pathogenic variant <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Arg141His</xref> is found in the compound heterozygous state in approximately 40% of individuals; it is never found in the homozygous state.</p>
                </list-item>
                <list-item>
                  <p>The pathogenic variant <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Phe119Leu</xref> is frequently found in northern Europe, where the genotype [p.Arg141His]+[p.Phe119Leu] makes up a majority of all pathogenic variants [<xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</xref>].</p>
                </list-item>
                <list-item>
                  <p>The pathogenic variants <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Val231Met</xref> and <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Pro113Leu</xref> are common all over Europe.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">PMM2</italic> and other genes of interest (see <xref ref-type="sec" rid="cdg-1a.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">PMM2</italic>) fails to confirm a diagnosis in an individual with features of PMM2-CDG (<italic toggle="yes">CDG-Ia)</italic>.</p>
              <p>For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="cdg-1a.T.summary_of_molecular_genetic_te" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cdg-1a.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_cdg-1a.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_cdg-1a.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cdg-1a.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">PMM2</italic>
                  </td>
                  <td headers="hd_h_cdg-1a.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_cdg-1a.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~100%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cdg-1a.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_cdg-1a.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cdg-1a.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="cdg-1a" object-id="cdg-1a.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="cdg-1a.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="cdg-1a.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="cdg-1a.TF.1.3">
                <label>3. </label>
                <p>Individuals with either an abnormal transferrin isoform pattern on analysis of serum transferrin glycoforms or enzymatically confirmed phosphomannomutase 2 deficiency [<xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2014">Jaeken et al 2014</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n8/full/ejhg2013298a.html">full text</ext-link>)</p>
              </fn>
              <fn id="cdg-1a.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="cdg-1a.TF.1.5">
                <label>5. </label>
                <p>
                  <xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2014">Jaeken et al [2014]</xref>
                </p>
              </fn>
              <fn id="cdg-1a.TF.1.6">
                <label>6. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="cdg-1a.TF.1.7">
                <label>7. </label>
                <p>A 28-kb deletion that includes exon 8 as well as other novel exon or whole-deletions has been reported [<xref ref-type="bibr" rid="cdg-1a.REF.schollen.2007.408">Schollen et al 2007</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Phosphomannomutase 2 (PMM2) enzyme activity.</bold> In individuals presenting with a severe/classic clinical picture of PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>), PMM2 enzyme activity in fibroblasts and leukocytes is typically 0% to 10% of normal [<xref ref-type="bibr" rid="cdg-1a.REF.van_schaftingen.1995.318">Van Schaftingen &#x00026; Jaeken 1995</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.carchon.1999.155">Carchon et al 1999</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.811">Jaeken &#x00026; Carchon 2001</xref>]. If measurement of enzyme activity is used to verify the diagnosis, use of leukocytes is preferable given that intermediate enzyme activity values (including values in the normal range) in fibroblasts have been reported [<xref ref-type="bibr" rid="cdg-1a.REF.gr_newald.2009.827">Gr&#x000fc;newald 2009</xref>].</p>
          <p><bold>Test characteristics.</bold> See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v22/n8/full/ejhg2013298a.html">Clinical Utility Gene Card</ext-link> [<xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2014">Jaeken et al 2014</xref>] for information on test characteristics including sensitivity and specificity.</p>
        </sec>
      </sec>
      <sec id="cdg-1a.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="cdg-1a.Clinical_Description">
          <title>Clinical Description</title>
          <p>The typical clinical course of PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) has been divided into an infantile multisystem type, late-infantile and childhood ataxia-intellectual disability type, and adult stable disability type. Recent reports have widened the phenotypic spectrum to include hydrops fetalis at the severe end [<xref ref-type="bibr" rid="cdg-1a.REF.van_de_kamp.2007.277">van de Kamp et al 2007</xref>] and a mild neurologic phenotype in adults with multisystem involvement at the mild end [<xref ref-type="bibr" rid="cdg-1a.REF.barone.2007.107">Barone et al 2007</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.coman.2007.668">Coman et al 2007</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.gr_newald.2009.827">Gr&#x000fc;newald 2009</xref>].</p>
          <sec id="cdg-1a.Infantile_Multisystem_Type">
            <title>Infantile Multisystem Type</title>
            <p>Historically, PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) was characterized by cerebellar hypoplasia, facial dysmorphism, psychomotor retardation, and abnormal subcutaneous fat distribution; however, the clinical phenotype continues to broaden.</p>
            <p>Infants show axial hypotonia, hyporeflexia, esotropia, and developmental delay. Feeding problems and vomiting may cause severe failure to thrive. Growth is significantly impaired [<xref ref-type="bibr" rid="cdg-1a.REF.kjaergaard.2002.324">Kjaergaard et al 2002</xref>]. Although distinctive facies (high nasal bridge and prominent jaw) and large ears have been reported in the northern European population, these features have not been emphasized in reports of affected individuals in the US [<xref ref-type="bibr" rid="cdg-1a.REF.krasnewich.1997.109">Krasnewich &#x00026; Gahl 1997</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.enns.2002.695">Enns et al 2002</xref>]. An unusual distribution of subcutaneous fat over the buttocks and the suprapubic region may be observed. In girls, the labia majora are involved as well. Inverted nipples are common.</p>
            <p>In one large study, two distinct clinical presentations were observed [<xref ref-type="bibr" rid="cdg-1a.REF.de_lonlay.2001.14">de Lonlay et al 2001</xref>]:</p>
            <list list-type="bullet">
              <list-item>
                <p>A purely neurologic form with strabismus, psychomotor retardation, and cerebellar hypoplasia early on, and neuropathy and retinitis pigmentosa in the first or second decade. This form was not fatal.</p>
              </list-item>
              <list-item>
                <p>A neurologic-multivisceral form in which manifestations occur early in life. All organs with the exception of the lungs can be involved. Hepatic fibrosis and renal hyperechogenicity are consistent. Some infants have hepatopathy, pericardial effusion, nephrotic syndrome, renal cysts, and multiorgan failure. Approximately 20% of affected infants die within the first year of life from failure to thrive, hypoalbuminemia, and aspiration pneumonia in what is called the "infantile catastrophic phase" characterized by intractable hypoalbuminemia, anasarca, and respiratory distress [<xref ref-type="bibr" rid="cdg-1a.REF.de_lonlay.2001.14">de Lonlay et al 2001</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.marquardt.2003.359">Marquardt &#x00026; Denecke 2003</xref>]. Strabismus and cerebellar hypoplasia are occasionally absent.</p>
              </list-item>
            </list>
            <p>Note: The relatively specific findings of PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) including dysmorphic features, inverted nipples, and abnormal fat pads may disappear with age and are occasionally absent in milder cases [<xref ref-type="bibr" rid="cdg-1a.REF.funke.2013.578">Funke et al 2013</xref>].</p>
            <p>Congenital cardiac anomalies, hypertrophic cardiomyopathy with transient myocardial ischemia, or cardiac effusions have been reported but are rare [<xref ref-type="bibr" rid="cdg-1a.REF.kristiansson.1998.112">Kristiansson et al 1998</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.marquardt.2002.524">Marquardt et al 2002</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.romano.2009.287">Romano et al 2009</xref>]. Pericardial effusions are typically without clinical sequelae and usually disappear in a year or two; however, persistent pericardial effusions have been seen in a few more medically involved cases, and have resulted in death in one individual [<xref ref-type="bibr" rid="cdg-1a.REF.truin.2008.481">Truin et al 2008</xref>].</p>
            <p>Liver function measurements begin to rise in the first year of life. Transaminases (AST and ALT) in young children may be in the range of 1000 to 1500 without clinical sequelae. Typically, the ALT and AST return to normal by age three to five years in children with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) and remain normal throughout their lives with occasional mild elevations during intercurrent illnesses. These children do not need a liver biopsy unless warranted by additional clinical evidence. Liver biopsy can demonstrate lamellar inclusions in macrophages and in hepatocyte lysosomes but not in Kupffer cell lysosomes [<xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</xref>].</p>
            <p>In general, children with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) are chemically euthyroid [<xref ref-type="bibr" rid="cdg-1a.REF.miller.2003.103">Miller &#x00026; Freeze 2003</xref>]. Note that measurement of thyroid binding globulin (TBG) may be low and thyroid stimulating hormone (TSH) may be transiently high. Free T4 should also be measured, as clinically relevant hypothyroidism in PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) is rare [<xref ref-type="bibr" rid="cdg-1a.REF.mohamed.2012.681">Mohamed et al 2012</xref>].</p>
            <p>Seizures, which are usually responsive to antiepileptic drugs, are common. In one study of 23 affected individuals who had seizures, the mean age of the first seizure was 17 months (range: 3-53 months) [<xref ref-type="bibr" rid="cdg-1a.REF.p_rezdue_as.2009.444">P&#x000e9;rez-Due&#x000f1;as et al 2009</xref>].</p>
            <p>Renal ultrasound examination in eight infants and children with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) showed no changes in the two with the neurologic form and increased cortical echogenicity and/or small pyramids that may or may not have been hyperechoic in the six with the multivisceral form [<xref ref-type="bibr" rid="cdg-1a.REF.hertzpannier.2006.108">Hertz-Pannier et al 2006</xref>]. Nephrotic syndrome is rare but has been reported [<xref ref-type="bibr" rid="cdg-1a.REF.sinha.2009.2591">Sinha et al 2009</xref>].</p>
            <p>Sibs with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) have been reported with immunologic dysfunction/diminished chemotaxis of neutrophils and poor immune response to vaccinations [<xref ref-type="bibr" rid="cdg-1a.REF.blank.2006.592">Blank et al 2006</xref>].</p>
            <p>One child with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) and a skeletal dysplasia, characterized by flattening of all vertebrae (platyspondyly), had severe spinal cord compression at the level of the craniocervical junction [<xref ref-type="bibr" rid="cdg-1a.REF.schade_van_westrum.2006.115">Schade van Westrum et al 2006</xref>].</p>
            <p>Osteopenia, seen on x-ray and also documented by densitometry, is common and remains throughout life.</p>
            <p>Lymphatic edema due to abnormal lymphatic vessel development has been described [<xref ref-type="bibr" rid="cdg-1a.REF.verstegen.2012.113">Verstegen et al 2012</xref>]. Note that this differs from the generalized edema resulting from hypoalbuminemia.</p>
          </sec>
          <sec id="cdg-1a.LateInfantile_and_Childhood_Ataxi">
            <title>Late-Infantile and Childhood Ataxia-Intellectual Disability Type</title>
            <p>Late-infantile and childhood ataxia-intellectual disability type occurs between ages three and ten years. Children have a more static course characterized by hypotonia and ataxia. Language and motor development are delayed and walking without support is rarely achieved [<xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</xref>]. IQ typically ranges from 40 to 70. As the spectrum of PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) expands, individuals with borderline and even normal development have been described [<xref ref-type="bibr" rid="cdg-1a.REF.giurgea.2005.121">Giurgea et al 2005</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.pancho.2005.230">Pancho et al 2005</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.barone.2007.107">Barone et al 2007</xref>]. The children usually are extroverted and cheerful. Seizures may occur; they are usually responsive to antiepileptic drugs.</p>
            <p>In this type and in adulthood, affected individuals may have stroke-like episodes or transient unilateral loss of function sometimes associated with fever, seizure, dehydration, or trauma. Recovery may occur over a few weeks to several months. Persistent neurologic deficits after a stroke-like episode occasionally occur but are rare. The etiology of these stroke-like episodes has not been fully elucidated. In one person, brain MRI demonstrated different findings after two such episodes, the first an ischemic process and the second edema with subsequent focal necrosis [<xref ref-type="bibr" rid="cdg-1a.REF.ishikawa.2009.240">Ishikawa et al 2009</xref>].</p>
            <p>Intracranial hemorrhage, while not common, has been described [<xref ref-type="bibr" rid="cdg-1a.REF.stefanits.2014.546">Stefanits et al 2014</xref>].</p>
            <p>A progressive peripheral neuropathy may begin in this age range.</p>
            <p>Retinitis pigmentosa due to a progressive photoreceptor degeneration [<xref ref-type="bibr" rid="cdg-1a.REF.thompson.2013.1039">Thompson et al 2013</xref>], myopia [<xref ref-type="bibr" rid="cdg-1a.REF.jensen.2003.81">Jensen et al 2003</xref>], cataract [<xref ref-type="bibr" rid="cdg-1a.REF.morava.2009.350">Morava et al 2009</xref>], joint contractures, and skeletal deformities may also occur.</p>
          </sec>
          <sec id="cdg-1a.Adult_Stable_Disability_Type">
            <title>Adult Stable Disability Type</title>
            <p>Adults with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) typically demonstrate stable rather than progressive intellectual disability and variable peripheral neuropathy.</p>
            <p>Progression of thoracic and spinal deformities can result in severe kyphoscoliosis. Osteopenia and osteoporosis are common in adults [<xref ref-type="bibr" rid="cdg-1a.REF.monin.2014.207">Monin et al 2014</xref>].</p>
            <p>Previously undiagnosed individuals are now being identified as adults because of multisystem involvement and cerebellar ataxia [<xref ref-type="bibr" rid="cdg-1a.REF.schoffer.2006.869">Schoffer et al 2006</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.barone.2007.107">Barone et al 2007</xref>]. Additionally the mild end of the adult phenotypic spectrum has expanded to include normal cognitive abilities; of three affected sibs, all had multisystem involvement, one with significant cognitive impairment and two with normal cognition [<xref ref-type="bibr" rid="cdg-1a.REF.stibler.1994.552">Stibler et al 1994</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.coman.2007.668">Coman et al 2007</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.krasnewich.2007.302">Krasnewich et al 2007</xref>].</p>
            <p>Women lack secondary sexual development as a result of hypogonadotropic hypogonadism [<xref ref-type="bibr" rid="cdg-1a.REF.de_zegher.1995.395">de Zegher &#x00026; Jaeken 1995</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.kristiansson.1995.655">Kristiansson et al 1995</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.miller.2003.103">Miller &#x00026; Freeze 2003</xref>]. In some females, laparoscopy and ultrasound examination have revealed absent ovaries. Males virilize normally at puberty but may exhibit decreased testicular volume.</p>
            <p>Other endocrine dysfunction includes hyperglycemia-induced growth hormone release, hyperprolactinemia, insulin resistance, and hyperinsulinemic hypoglycemia [<xref ref-type="bibr" rid="cdg-1a.REF.miller.2003.103">Miller &#x00026; Freeze 2003</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.shanti.2009.s241">Shanti et al 2009</xref>]. Glycosylation and resultant function of IGFBP3 and an acid-labile subunit (ALS) in the IGF pathway are impaired in CDG [<xref ref-type="bibr" rid="cdg-1a.REF.miller.2009.892">Miller et al 2009</xref>].</p>
            <p>Coagulopathy with decreased serum concentrations of factors IV, IX, and XI, antithrombin III, protein C, and protein S may be present. Deep venous thrombosis in adults has been reported [<xref ref-type="bibr" rid="cdg-1a.REF.krasnewich.2007.302">Krasnewich et al 2007</xref>].</p>
            <p>Renal microcysts may be identified on renal ultrasound examination but renal function is typically preserved throughout adulthood [<xref ref-type="bibr" rid="cdg-1a.REF.str_m.1993.253">Str&#x000f8;m et al 1993</xref>].</p>
            <p><bold>Neuroimaging.</bold> An enlarged cisterna magna and superior cerebellar cistern is observed in late infancy to early childhood. Occasionally, both infratentorial and supratentorial changes compatible with atrophy are present. Dandy-Walker malformations and small white matter cysts have been reported [<xref ref-type="bibr" rid="cdg-1a.REF.peters.2002.27">Peters et al 2002</xref>].</p>
            <p>Myelination varies from normal to delayed or insufficient [<xref ref-type="bibr" rid="cdg-1a.REF.holzbach.1995.781">Holzbach et al 1995</xref>].</p>
            <p>Serial CTs performed on three children with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) revealed that enlargement of the spaces between the folia of the cerebellar hemispheres, especially from the anterior to the posterior aspect, as well as atrophy of the anterior vermis, appeared to progress until around age five years [<xref ref-type="bibr" rid="cdg-1a.REF.akaboshi.1995.491">Akaboshi et al 1995</xref>]. Progression of cerebellar atrophy on MRI after age five years is variable. After age nine years, cerebellar atrophy did not appear to progress. Development of the supratentorial structures was normal.</p>
          </sec>
        </sec>
        <sec id="cdg-1a.Pathophysiology">
          <title>Pathophysiology</title>
          <p>PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) is caused by deficiency of phosphomannomutase 2 (PMM2) enzyme activity resulting in the defective synthesis of N-linked oligosaccharides, sugars linked together in a specific pattern and attached to proteins and lipids (N-linked glycans link to the amide group of asparagine via an N-acetylglucosamine residue) [<xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.grunewald.2002.618">Grunewald et al 2002</xref>]. Because of the important biologic functions of the oligosaccharides in both glycoproteins and glycolipids, incorrect synthesis of these compounds results in multisystem clinical manifestations [<xref ref-type="bibr" rid="cdg-1a.REF.varki.1993.97">Varki 1993</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.freeze.2006.537">Freeze 2006</xref>].</p>
          <p>See <xref ref-type="fig" rid="cdg-1a.F1">Figure 1</xref>.</p>
        </sec>
        <sec id="cdg-1a.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Lack of correlation between genotype and phenotype in PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) has been reported [<xref ref-type="bibr" rid="cdg-1a.REF.erlandson.2001.359">Erlandson et al 2001</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.westphal.2001.71">Westphal et al 2001</xref>]. In general, individuals with all genotypes show the basic signs of the disorder; i.e., developmental delay, cerebellar atrophy, peripheral neuropathy, stroke-like episodes or comatose episodes, epilepsy, retinal pigmentary degeneration, strabismus, skeletal abnormalities, and hepatopathy. However, the extent of the non-neurologic findings varies depending on the genotype:</p>
          <list list-type="bullet">
            <list-item>
              <p>C-terminal pathogenic variants, including <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.His218Leu</xref>, <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Thr237Met</xref>, and <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Cys241Ser</xref>, may be associated with a milder phenotype [<xref ref-type="bibr" rid="cdg-1a.REF.matthijs.1999.220">Matthijs et al 1999</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.tayebi.2002.241">Tayebi et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>The phenotypic spectrum of the [<xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Arg141His</xref>]+[<xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Phe119Leu</xref>] genotype, the most prevalent genotype in PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>), was studied in Scandinavia [<xref ref-type="bibr" rid="cdg-1a.REF.kjaergaard.2001.236">Kjaergaard et al 2001</xref>]. Individuals with the [p.Arg141His]+[p.Phe119Leu] genotype probably represent the severe end of the clinical spectrum of <italic toggle="yes">CDG-Ia</italic>. Presentation was uniformly early with severe feeding problems, severe failure to thrive, severe hypotonia, developmental delay obvious before age six months, and hepatic dysfunction. Asymptomatic pericardial effusions were common in the first year of life. The functional outcome in ambulation and speech was variable.</p>
            </list-item>
            <list-item>
              <p>A severe phenotype presenting with a high mortality rate was observed with the [<xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Asp188Gly</xref>]+[p.Arg141His] genotype: in the study by <xref ref-type="bibr" rid="cdg-1a.REF.matthijs.1998.542">Matthijs et al [1998]</xref>, four of five children with this genotype died before age two years. The remaining child, age ten years, was severely affected.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="cdg-1a.REF.de_lonlay.2001.14">de Lonlay et al [2001]</xref> reported several compound heterozygous genotypes (including [p.Arg141His]+[ <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Thr226Ser</xref>], [p.Arg141His]+[<xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Ile132Thr</xref>], and [p.Arg141His]+[<xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Glu139Lys</xref>]) that appear to be associated with a milder phenotype termed the "neurologic form" without pericardial effusions, coagulation defects, or nutritional disturbances. Some individuals are able to walk independently.</p>
            </list-item>
            <list-item>
              <p>The pathogenic variant <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Val231Met</xref> is associated with high early mortality and severe multi-organ insufficiency.</p>
            </list-item>
            <list-item>
              <p>Homozygosity or compound heterozygosity for pathogenic variants with virtually no residual activity (e.g., p.Arg141His) is likely incompatible with life [<xref ref-type="bibr" rid="cdg-1a.REF.matthijs.2000.386">Matthijs et al 2000</xref>].</p>
            </list-item>
            <list-item>
              <p>The pathogenic variant <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">p.Leu32Arg</xref>, which is particularly frequent in Italy, is associated with a milder phenotype with preserved ambulation and mild cognitive impairment despite cerebellar hypoplasia on brain MRI [<xref ref-type="bibr" rid="cdg-1a.REF.barone.2015.154">Barone et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>A relatively common mild <italic toggle="yes">ALG6</italic> variant (p.Phe304Ser) in combination with confirmed PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) may exacerbate the clinical severity in PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>); however, this information cannot currently be used to predict clinical outcome [<xref ref-type="bibr" rid="cdg-1a.REF.westphal.2002.599">Westphal et al 2002</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.bortot.2013.506">Bortot et al 2013</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="cdg-1a.Nomenclature">
          <title>Nomenclature</title>
          <p>In 2009 the nomenclature for all types of CDG was changed to include the official gene symbol (not in italics) followed by &#x0201c;-CDG&#x0201d;. If the type has a known letter name, it follows in parenthesis; thus the new nomenclature for this disorder is PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) [<xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2009.825">Jaeken et al 2009</xref>].</p>
          <p>PMM2-CDG was previously referred to as CDGS1a; carbohydrate-deficient glycoprotein syndrome, type 1a; and Jaeken syndrome.</p>
        </sec>
        <sec id="cdg-1a.Prevalence">
          <title>Prevalence</title>
          <p>PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) is the most common form of <related-object link-type="booklink" source-id="gene" document-id="cdg" document-type="chapter">congenital disorders of glycosylation</related-object>. The prevalence could be as high as 1:20,000 [<xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</xref>].</p>
          <p>The expected carrier frequency for a <italic toggle="yes">PMM2</italic> pathogenic variant in the Danish population is 1:60 to 1:79 [<xref ref-type="bibr" rid="cdg-1a.REF.matthijs.2000.386">Matthijs et al 2000</xref>].</p>
        </sec>
      </sec>
      <sec id="cdg-1a.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">PMM2</italic>.</p>
      </sec>
      <sec id="cdg-1a.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Any child with evidence of coagulopathy, hepatopathy, elevated thyroid stimulating hormone (TSH), or cerebellar hypoplasia <bold>and</bold> the triad of hypotonia, developmental delay, and failure to thrive should be evaluated for PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>).</p>
        <p>
          <bold>Other genetic disorders to consider in the differential diagnosis</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="pws" document-type="chapter">Prader-Willi syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Congenital muscular dystrophies including <related-object link-type="booklink" source-id="gene" document-id="fcmd" document-type="chapter">Fukuyama congenital muscular dystrophy</related-object> (FCMD) caused by mutation of <italic toggle="yes">FKTN</italic>, muscle-eye-brain (MEB) disease caused by mutation of <italic toggle="yes">POMGNT1</italic> [<xref ref-type="bibr" rid="cdg-1a.REF.yoshida.2001.717">Yoshida et al 2001</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.martin.2003.67r">Martin &#x00026; Freeze 2003</xref>], and Walker-Warburg syndrome, caused by mutation of <italic toggle="yes">POMT1</italic> (see <related-object link-type="booklink" source-id="gene" document-id="cmd-overview" document-type="chapter">Congenital Muscular Dystrophies Overview)</related-object></p>
          </list-item>
          <list-item>
            <p>Congenital myopathies (e.g., <related-object link-type="booklink" source-id="gene" document-id="mtm" document-type="chapter">X-linked myotubular myopathy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="mmd" document-type="chapter">multiminicore disease</related-object>)</p>
          </list-item>
        </list>
        <p>Many metabolic and genetic disorders that present in infancy share at least some of the clinical features of PMM2-CDG (<italic toggle="yes">CDG-Ia)</italic>. The following metabolic disorders are in the differential diagnosis of hypotonia, developmental delay, and failure to thrive:</p>
        <list list-type="bullet">
          <list-item>
            <p>Mitochondrial disorders (see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>)</p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="pbd" document-type="chapter">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Urea cycle defects (see <related-object link-type="booklink" source-id="gene" document-id="ucd-overview" document-type="chapter">Urea Cycle Disorders Overview</related-object>)</p>
          </list-item>
        </list>
      </sec>
      <sec id="cdg-1a.Management">
        <title>Management</title>
        <sec id="cdg-1a.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) the following evaluations are recommended [<xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.811">Jaeken &#x00026; Carchon 2001</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2001.129">Jaeken &#x00026; Matthijs 2001</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.grunewald.2002.618">Grunewald et al 2002</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.kjaergaard.2002.324">Kjaergaard et al 2002</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.miller.2003.103">Miller &#x00026; Freeze 2003</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.gr_newald.2009.827">Gr&#x000fc;newald 2009</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Liver function tests</p>
            </list-item>
            <list-item>
              <p>Measurement of serum albumin concentration</p>
            </list-item>
            <list-item>
              <p>Thyroid function tests to evaluate for decreased thyroid binding globulin, elevated serum concentration of TSH, and low serum concentration of free T4</p>
            </list-item>
            <list-item>
              <p>Coagulation studies including protein C, protein S, antithrombin III, and factor IX</p>
            </list-item>
            <list-item>
              <p>Urinalysis to evaluate for proteinuria</p>
            </list-item>
            <list-item>
              <p>Measurement of serum concentration of gonadotropins in adolescent and adult women to look for evidence of hypogonadotropic hypogonadism</p>
            </list-item>
            <list-item>
              <p>Echocardiogram to evaluate for pericardial effusions</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound examination to evaluate for microcysts</p>
            </list-item>
            <list-item>
              <p>Formal ophthalmologic evaluation since ocular anomalies are frequent and can involve both the structural components (development of the lens and retina) as well as ocular mobility and intraocular pressure [<xref ref-type="bibr" rid="cdg-1a.REF.morava.2009.350">Morava et al 2009</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.thompson.2013.1039">Thompson et al 2013</xref>]</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor with inclusion in a multi-disciplinary team if needed</p>
            </list-item>
          </list>
        </sec>
        <sec id="cdg-1a.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Failure to thrive.</bold> Infants and children can be nourished with any type of formula for maximal caloric intake. They can tolerate carbohydrates, fats, and protein. Early in life, children may do better on elemental formulas. Their feeding may be advanced based on their oral motor function. Some children require placement of a nasogastric tube or gastrostomy tube for nutritional support until oral motor skills improve.</p>
          <p><bold>Oral motor dysfunction with persistent vomiting.</bold> Thickening of feeds, maintenance of an upright position after eating, and antacids can help children who experience gastroesophageal reflux and/or persistent vomiting. Consultation with a gastroenterologist and nutritionist is often necessary. Children with a gastrostomy tube should be encouraged to eat by mouth if the risk of aspiration is low. Continued speech therapy and oral motor therapy aid transition to oral feeds and encourage speech when the child is developmentally ready.</p>
          <p><bold>Developmental delay.</bold> Occupational therapy, physical therapy, and speech therapy should be instituted. As the developmental gap widens between children with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) and their unaffected peers, parents need continued counseling and support.</p>
          <p><bold>"Infantile catastrophic phase."</bold> Very rarely, infants may have a complicated early course presenting with infection or seizure and hypoalbuminemia with third spacing that may progress to anasarca. Some children are responsive to aggressive albumin replacement with lasix, others may have a more refractory course. Symptomatic treatment in a pediatric tertiary care center is recommended. Parents should also be advised that some infants with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) never experience a hospital visit while others may require frequent hospitalizations.</p>
          <p><bold>Strabismus.</bold> Intervention by a pediatric ophthalmologist early in life is important to preserve vision through glasses, patching, or surgery.</p>
          <p><bold>Hypothyroidism.</bold> Thyroid function tests are frequently abnormal in children with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>). However, free thyroxine analyzed by equilibrium dialysis, the most accurate method, has been reported as normal in seven individuals with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>). Diagnosis of hypothyroidism and L-thyroxine supplementation should be reserved for those children and adults with elevated TSH and low free thyroxine measured by equilibrium dialysis.</p>
          <p><bold>Stroke-like episodes.</bold> Supportive therapy includes hydration by IV if necessary and physical therapy during the recovery period.</p>
          <p><bold>Coagulopathy.</bold> Low levels of coagulation factors, both pro- and anti-coagulant, rarely cause clinical problems in daily activities but must be acknowledged if an individual with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) undergoes surgery. Consultation with a hematologist (to document the coagulation status and factor levels) and discussion with the surgeon are important. When necessary, infusion of fresh frozen plasma corrects the factor deficiency and clinical bleeding. The potential for imbalance of the level of both pro- and anti-coagulant factors may lead to either bleeding or thrombosis. Care givers, especially of older affected individuals, should be taught the signs of deep venous thrombosis.</p>
          <p><bold>Osteopenia.</bold> While present from infancy there does not appear to be a significant increased risk of fracture. Should fracture occur, management should follow standards of medical care.</p>
          <p>
            <bold>Additional management issues of adults with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>)</bold>
          </p>
          <p><bold>Orthopedic issues&#x02014;thorax shortening, scoliosis/kyphosis.</bold> Management involves appropriate orthopedic and physical medicine management, well-supported wheelchairs, appropriate transfer devices for the home, and physical therapy. Occasionally, surgical treatment of spinal curvature is warranted.</p>
          <p><bold>Deep venous thrombosis (DVT).</bold> DVT has been reported in two adults with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>). Rapid diagnosis and treatment of DVT are essential to minimize the risk of pulmonary emboli; sedentary affected adults and children are at increased risk for DVT.</p>
          <p><bold>Independent living issues.</bold> Young adults with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) and their parents need to address issues of independent living. Aggressive education throughout the school years in functional life skills and/or vocational training helps the transition when schooling is completed. Independence in self-care and the activities of daily living should be encouraged. Support and resources for parents of a disabled adult are an important part of management.</p>
        </sec>
        <sec id="cdg-1a.Prevention_of_Secondary_Complicat">
          <title>Prevention of Secondary Complications</title>
          <p>Because infants with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) have less physiologic reserve than their peers, parents should have a low threshold for evaluation by a physician for prolonged fever, vomiting, or diarrhea. Aggressive intervention with antipyretics, antibiotics if warranted, and hydration may prevent the morbidity associated with the "infantile catastrophic phase."</p>
          <p>Although only one individual with skeletal dysplasia in PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) has been reported, plain spine films assessing cervical spine anomalies may be useful [<xref ref-type="bibr" rid="cdg-1a.REF.schade_van_westrum.2006.115">Schade van Westrum et al 2006</xref>].</p>
        </sec>
        <sec id="cdg-1a.Surveillance">
          <title>Surveillance</title>
          <p>
            <bold>Annual</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment by a physician with attention to overall health and referral for speech therapy, occupational therapy, and physical therapy</p>
            </list-item>
            <list-item>
              <p>Eye examination</p>
            </list-item>
            <list-item>
              <p>Liver function tests, thyroid panel, protein C, protein S, factor IX, and antithrombin III</p>
            </list-item>
          </list>
          <p>
            <bold>Other</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Periodic assessment of bleeding and clotting parameters by a hematologist</p>
            </list-item>
            <list-item>
              <p>Monitoring for osteopenia/osteoporosis and counseling about the risk of fractures</p>
            </list-item>
            <list-item>
              <p>Follow up with an orthopedist when scoliosis becomes evident</p>
            </list-item>
          </list>
        </sec>
        <sec id="cdg-1a.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Acetaminophen and other agents metabolized by the liver should be used with caution.</p>
        </sec>
        <sec id="cdg-1a.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="cdg-1a.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cdg-1a.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="cdg-1a.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cdg-1a.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="cdg-1a.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">PMM2</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, the theoretic risks to sibs of an affected individual are a 25% risk of being affected, a 50% risk of being an asymptomatic carrier, and a 25% risk of being unaffected and not a carrier. However, based on outcomes of at-risk pregnancies, the risk of having an affected child is closer to 1/3 than to the expected 1/4 [<xref ref-type="bibr" rid="cdg-1a.REF.schollen.2004.877">Schollen et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Adults with PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) have not been reported to reproduce.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">PMM2</italic> pathogenic variant.</p>
        </sec>
        <sec id="cdg-1a.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">PMM2</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="cdg-1a.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Increased recurrence risk for PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>).</bold> Studies of the outcomes of prenatal testing suggest that the percentage of affected fetuses is higher than predicted by Mendel&#x02019;s second law. The risk to sibs of a proband is estimated to be closer to 1/3 than to the expected 1/4. This finding of an apparent increased recurrence risk caused by transmission ratio distortion continues to be validated [<xref ref-type="bibr" rid="cdg-1a.REF.schollen.2004.877">Schollen et al 2004</xref>].</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are at risk of being heterozygotes (i.e., carriers of one <italic toggle="yes">PMM2</italic> pathogenic variant).</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="cdg-1a.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>High a priori risk.</bold> Once the <italic toggle="yes">PMM2</italic> pathogenic variants have been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) are possible.</p>
          <p><bold>Low a priori risk.</bold> PMM2-CDG (<italic toggle="yes">CDG-Ia</italic>) molecular testing should be considered in non-immune hydrops fetalis [<xref ref-type="bibr" rid="cdg-1a.REF.van_de_kamp.2007.277">van de Kamp et al 2007</xref>].</p>
          <p>Note: Transferrin isoform analysis on fetal serum is an unreliable diagnostic test. PMM enzyme activity may also be falsely low in poor-growing amniocytes or chorionic villi.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="cdg-1a.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cdg-1a.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">PMM2</italic> is 51.49 kb with eight exons and codes for a transcript length of 2290 bp. Northern blot analysis shows the highest expression of <italic toggle="yes">PMM2</italic> in the pancreas and liver with weak expression in brain, in contrast to <italic toggle="yes">PMM1,</italic> which is highly expressed in brain. A processed pseudogene, <italic toggle="yes">PMM2P1</italic>, has been identified on chromosome 18 [<xref ref-type="bibr" rid="cdg-1a.REF.schollen.1998.157">Schollen et al 1998</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cdg-1a" object-id="cdg-1a.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> See <xref ref-type="table" rid="cdg-1a.T.selected_pmm2_pathogenic_varian">Table 2</xref>. More than 100 pathogenic variants have been reported, including missense, nonsense, and frameshift variants, splicing defects, and complete loss of exon 8 due to a deletion mediated by an Alu retrotransposition [<xref ref-type="bibr" rid="cdg-1a.REF.haeuptle.2009.1628">Haeuptle &#x00026; Hennet 2009</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.p_rez.2011.117">P&#x000e9;rez et al 2011</xref>, <xref ref-type="bibr" rid="cdg-1a.REF.jaeken.2014">Jaeken et al 2014</xref>].</p>
        <p>The p.Arg141His pathogenic variant is the most common in northern European populations; p.Phe119Leu is the second most common. <xref ref-type="bibr" rid="cdg-1a.REF.kjaergaard.1998.331">Kjaergaard et al [1998]</xref> reported that these two pathogenic variants together accounted for 88% of all pathogenic variants in the Danish population.</p>
        <table-wrap id="cdg-1a.T.selected_pmm2_pathogenic_varian" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">PMM2</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequence</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.95T&#x0003e;G</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu32Arg</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_3" rowspan="12" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;val=NM_000303.2">NM_000303.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000294.1">NP_000294.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.338C&#x0003e;T</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro113Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.357C&#x0003e;A</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe119Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.395T&#x0003e;C</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile132Thr</td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.415G&#x0003e;A</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu139Lys</td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.422G&#x0003e;A</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg141His</td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.563A&#x0003e;G</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp188Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.653A&#x0003e;T</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His218Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.677C&#x0003e;G</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr226Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.691G&#x0003e;A</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val231Met</td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.710C&#x0003e;T</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr237Met</td>
              </tr>
              <tr>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.722G&#x0003e;C</td>
                <td headers="hd_h_cdg-1a.T.selected_pmm2_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys241Ser</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The product of <italic toggle="yes">PMM2</italic> is a 246-amino acid protein with an approximate molecular weight of 28.1 kd. Phosphomannomutase 2 is an enzyme required for the synthesis of GDP-mannose specifically involved in the conversion of mannose-6-phosphate to mannose-1-phosphate, which is then transformed to GDP-mannose, a precursor of mannose for the biosynthesis of N-glycoproteins.</p>
        <p><bold>Abnormal gene product.</bold> The abnormal phosphomannomutase 2 protein causes hypoglycosylation by lowering the intracellular mannose-1-phosphate pool, producing dysfunctional proteins leading to deficient synthesis of GDP-mannose and incorrect N-linked oligosaccharide synthesis.</p>
      </sec>
      <sec id="cdg-1a.References">
        <title>References</title>
        <sec id="cdg-1a.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cdg-1a.Literature_Cited.reflist0">
            <ref id="cdg-1a.REF.akaboshi.1995.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Akaboshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeshita</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Neuroradiological findings in the carbohydrate-deficient glycoprotein syndrome.</article-title>
                <source>Neuroradiology</source>
                <volume>37</volume>
                <fpage>491</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7477867</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.aronica.2005.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aronica</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Kempen</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Heide</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poll-The</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Slooten</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troost</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozemuller-Kwakkel</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>109</volume>
                <fpage>433</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">15714316</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.barone.2015.154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrozzi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lilliu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciana</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leuzzi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leoni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sturiale</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Rocco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garozzo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiumara</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation.</article-title>
                <source>J Neurol.</source>
                <volume>262</volume>
                <fpage>154</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">25355454</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.barone.2007.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sturiale</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiumara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garozzo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype).</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>30</volume>
                <fpage>107</fpage>
                <pub-id pub-id-type="pmid">17186415</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.blank.2006.592">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blank</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fehrenbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeLisser</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Recurrent infections and immunological dysfunction in congenital disorder of glycosylation Ia (CDG Ia).</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>29</volume>
                <fpage>592</fpage>
                <pub-id pub-id-type="pmid">16826448</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.bortot.2013.506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bortot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cosentini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faletra</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biffi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Martino</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrozzi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Severini</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>PMM2-CDG: phenotype and genotype in four affected family members.</article-title>
                <source>Gene.</source>
                <volume>531</volume>
                <fpage>506</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23988505</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.carchon.1999.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carchon</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Schaftingen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency).</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1455</volume>
                <fpage>155</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">10571009</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.carchon.2006.774">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carchon</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nsibu Ndosimao</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Aerschot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Use of serum on guthrie cards in screening for congenital disorders of glycosylation.</article-title>
                <source>Clin Chem</source>
                <volume>52</volume>
                <fpage>774</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16595835</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.clayton.1992.857">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clayton</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winchester</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keir</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Hypertrophic obstructive cardiomyopathy in a neonate with the carbohydrate-deficient glycoprotein syndrome.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>15</volume>
                <fpage>857</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">1293380</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.coman.2007.668">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGill</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klingberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appleton</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Congenital disorder of glycosylation type 1a: Three siblings with a mild neurological phenotype.</article-title>
                <source>J Clin Neurosci</source>
                <volume>14</volume>
                <fpage>668</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">17451957</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.de_lonlay.2001.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabriel</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Journel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurent</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedespan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villeneuve</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Schaftingen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases.</article-title>
                <source>J Med Genet</source>
                <volume>38</volume>
                <fpage>14</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11134235</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.de_zegher.1995.395">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Zegher</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence.</article-title>
                <source>Pediatr Res</source>
                <volume>37</volume>
                <fpage>395</fpage>
                <lpage>401</lpage>
                <pub-id pub-id-type="pmid">7596677</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.enns.2002.695">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steiner</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buist</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppig</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCracken</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westphal</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeze</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Behera</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudgins</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins.</article-title>
                <source>J Pediatr</source>
                <volume>141</volume>
                <fpage>695</fpage>
                <lpage>700</lpage>
                <pub-id pub-id-type="pmid">12410200</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.erlandson.2001.359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Erlandson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjursell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stibler</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kristiansson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wahlstrom</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinsson</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations.</article-title>
                <source>Hum Genet</source>
                <volume>108</volume>
                <fpage>359</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">11409861</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.fletcher.2000.396">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fletcher</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Schaftingen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>PV</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Carbohydrate-deficient glycoprotein syndrome: beyond the screen.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>23</volume>
                <fpage>396</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10896303</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.freeze.2006.537">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freeze</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Genetic defects in the human glycome.</article-title>
                <source>Nat Rev Genet</source>
                <volume>7</volume>
                <fpage>537</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">16755287</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.funke.2013.578">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Funke</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardeitchik</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kouwenberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohamed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wortmann</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adamowicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Gazali</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefeber</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Perinatal and early infantile symptoms in congenital disorders of glycosylation.</article-title>
                <source>Am J Med Genet A</source>
                <volume>161A</volume>
                <fpage>578</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">23401092</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.giurgea.2005.121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giurgea</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Underdiagnosis of mild congenital disorders of glycosylation type Ia.</article-title>
                <source>Pediatr Neurol.</source>
                <volume>32</volume>
                <fpage>121</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15664773</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.gr_newald.2009.827">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gr&#x000fc;newald</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).</article-title>
                <source>Biochim Biophys Acta.</source>
                <volume>1792</volume>
                <fpage>827</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">19272306</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.grunewald.2002.618">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grunewald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Congenital disorders of glycosylation: a review.</article-title>
                <source>Pediatr Res.</source>
                <volume>52</volume>
                <fpage>618</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">12409504</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.haeuptle.2009.1628">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haeuptle</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennet</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides.</article-title>
                <source>Hum Mutat</source>
                <volume>30</volume>
                <fpage>1628</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">19862844</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.hahn.2006.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minnich</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Brien</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Stabilization of hypoglycosylation in a patient with congenital disorder of glycosylation type Ia.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>29</volume>
                <fpage>235</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16601903</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.hertzpannier.2006.108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hertz-Pannier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dechaux</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinico</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emond</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunelle</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niaudet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Congenital disorders of glycosylation type I: a rare but new cause of hyperechoic kidneys in infants and children due to early microcystic changes.</article-title>
                <source>Pediatr Radiol</source>
                <volume>36</volume>
                <fpage>108</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">16328327</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.holzbach.1995.781">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holzbach</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helms</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanicke</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frahm</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Localized proton magnetic resonance spectroscopy of cerebral abnormalities in children with carbohydrate-deficient glycoprotein syndrome.</article-title>
                <source>Acta Paediatr</source>
                <volume>84</volume>
                <fpage>781</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">7549297</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.ishikawa.2009.240">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tajima</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ono</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Different neuroradiological findings during two stroke-like episodes in a patient with congenital disorder of glycosylation type Ia.</article-title>
                <source>Brain Dev.</source>
                <year>2009</year>
                <volume>31</volume>
                <fpage>240</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18485644</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.jaeken.2001.811">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carchon</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Congenital disorders of glycosylation: the rapidly growing tip of the iceberg.</article-title>
                <source>Curr Opin Neurol</source>
                <volume>14</volume>
                <fpage>811</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11723393</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.jaeken.2001.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Congenital disorders of glycosylation.</article-title>
                <source>Annu Rev Genomics Hum Genet</source>
                <volume>2</volume>
                <fpage>129</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">11701646</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.jaeken.2009.825">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennet</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeze</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>CDG nomenclature: time for a change!</article-title>
                <source>Biochim Biophys Acta.</source>
                <volume>1792</volume>
                <fpage>825</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19765534</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.jaeken.2014">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefeber</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Clinical utility gene card for: Phosphomannomutase 2 deficiency.</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>22</volume>
                <issue>8</issue>
                <pub-id pub-id-type="pmid">24424124</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.jensen.2003.81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjaergaard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klie</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>HU</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Ophthalmic manifestations of congenital disorder of glycosylation type 1a.</article-title>
                <source>Ophthalmic Genet</source>
                <volume>24</volume>
                <fpage>81</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12789572</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.kjaergaard.2002.324">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kjaergaard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skovby</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Prepubertal growth in congenital disorder of glycosylation type Ia (CDG-Ia).</article-title>
                <source>Arch Dis Child</source>
                <volume>87</volume>
                <fpage>324</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12244009</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.kjaergaard.2001.236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kjaergaard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skovby</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype.</article-title>
                <source>Arch Dis Child</source>
                <volume>85</volume>
                <fpage>236</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11517108</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.kjaergaard.1998.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kjaergaard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skovby</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>6</volume>
                <fpage>331</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9781039</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.krasnewich.1997.109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahl</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Carbohydrate-deficient glycoprotein syndrome.</article-title>
                <source>Adv Pediatr</source>
                <volume>44</volume>
                <fpage>109</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">9265969</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.krasnewich.2007.302">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Brien</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sparks</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia).</article-title>
                <source>Am J Med Genet</source>
                <volume>145C</volume>
                <fpage>302</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17639595</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.kristiansson.1998.112">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kristiansson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stibler</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conradi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eriksson</surname>
                    <given-names>BO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryd</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>The heart and pericardial effusions in CDGS-I (carbohydrate-deficient glycoprotein syndrome type I).</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>21</volume>
                <fpage>112</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">9584262</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.kristiansson.1995.655">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kristiansson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stibler</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wide</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome.</article-title>
                <source>Acta Paediatr</source>
                <volume>84</volume>
                <fpage>655</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">7670249</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.l_tic_e.2010.253">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000e9;tic&#x000e9;e</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bessi&#x000e8;res-Grattagliano</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupr&#x000e9;</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuillaumier-Barrot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Khartoufi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ville</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouvier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atti&#x000e9;-Bitach</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>Should PMM2-deficiency (CDG-Ia) be searched in every case of unexplained hydrops fetalis?</article-title>
                <source>Mol Genet Metab.</source>
                <year>2010</year>
                <volume>101</volume>
                <fpage>253</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20638314</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.marklov_.2007.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marklov&#x000e1;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albahri</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Screening and diagnosis of congenital disorders of glycosylation.</article-title>
                <source>Clin Chim Acta.</source>
                <volume>385</volume>
                <fpage>6</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">17716641</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.marquardt.2003.359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marquardt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denecke</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies.</article-title>
                <source>Eur J Pediatr</source>
                <volume>162</volume>
                <fpage>359</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">12756558</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.marquardt.2002.524">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marquardt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulskamp</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gehrmann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debus</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harms</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kehl</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Severe transient myocardial ischaemia caused by hypertrophic cardiomyopathy in a patient with congenital disorder of glycosylation type Ia.</article-title>
                <source>Eur J Pediatr</source>
                <volume>161</volume>
                <fpage>524</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12297897</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.martin.2003.67r">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeze</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Glycobiology of neuromuscular disorders.</article-title>
                <source>Glycobiology</source>
                <volume>13</volume>
                <fpage>67R</fpage>
                <lpage>75R</lpage>
                <pub-id pub-id-type="pmid">12736200</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.matthijs.2000.386">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schollen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjursell</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erlandson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeze</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imtiaz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjaergaard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinsson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuillaumier-Barrot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westphal</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winchester</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).</article-title>
                <source>Hum Mutat</source>
                <volume>16</volume>
                <fpage>386</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">11058895</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.matthijs.1999.220">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schollen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heykants</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grunewald</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia).</article-title>
                <source>Mol Genet Metab</source>
                <volume>68</volume>
                <fpage>220</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10527672</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.matthijs.1998.542">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schollen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Schaftingen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassiman</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A.</article-title>
                <source>Am J Hum Genet</source>
                <volume>62</volume>
                <fpage>542</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">9497260</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.miller.2003.103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeze</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>New disorders in carbohydrate metabolism: congenital disorders of glycosylation and their impact on the endocrine system.</article-title>
                <source>Rev Endocr Metab Disord</source>
                <volume>4</volume>
                <fpage>103</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">12618564</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.miller.2009.892">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khosravi</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conover</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>IGF system in children with congenital disorders of glycosylation.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>70</volume>
                <fpage>892</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19207313</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.mohamed.2012.681">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mohamed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodore</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claahsen-van der Grinten</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Herwaarden</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huijben</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dongen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kouwenberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefeber</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Thyroid function in PMM2-CDG: diagnostic approach and proposed management.</article-title>
                <source>Mol Genet Metab.</source>
                <volume>105</volume>
                <fpage>681</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">22386715</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.monin.2014.207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Monin</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e9;ron</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masurel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathieu-Dramard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenaerts</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thauvin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e9;rard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquette</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charles</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Barac&#x000e9;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin-Garraud</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khau Van Kien</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e9;ron</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <volume>9</volume>
                <fpage>207</fpage>
                <pub-id pub-id-type="pmid">25497157</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.morava.2009.350">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wosik</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykut-Cegielska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adamowicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefeber</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruysberg</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Ophthalmological abnormalities in children with congenital disorders of glycosylation type I.</article-title>
                <source>Br J Ophthalmol</source>
                <volume>93</volume>
                <fpage>350</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19019927</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.pancho.2005.230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pancho</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Cazorla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varea</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artuch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilaseca</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briones</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campistol</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Congenital disorder of glycosylation type Ia revealed by hypertransaminasemia and failure to thrive in a young boy with normal development.</article-title>
                <source>J Pediatr Gastroenterol Nutr.</source>
                <year>2005</year>
                <volume>40</volume>
                <fpage>230</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15699704</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.park.2014.135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000fc;hlsdorf</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roll</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rust</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Du Chesne</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;neberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reunert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquardt</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>The novel transferrin E592A variant impairs the diagnostics of congenital disorders of glycosylation.</article-title>
                <source>Clin Chim Acta</source>
                <volume>436</volume>
                <fpage>135</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24875750</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.p_rez.2011.117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briones</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quelhas</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artuch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vega</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quintana</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gort</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ecay</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>The molecular landscape of phosphomannose mutase deficiency in Iberian peninsula: identification of 15 population-specific mutations.</article-title>
                <source>JIMD Rep</source>
                <volume>1</volume>
                <fpage>117</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">23430838</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.p_rezdue_as.2009.444">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Due&#x000f1;as</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Cazorla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pineda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campistol</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cus&#x000ed;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schollen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grunewald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briones</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artuch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilaseca</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <volume>13</volume>
                <fpage>444</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">18948042</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.peters.2002.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penzien</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reiter</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackler</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heidemann</surname>
                    <given-names>PH</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Congenital disorder of glycosylation IId (CDG-IId) -- a new entity: clinical presentation with Dandy-Walker malformation and myopathy.</article-title>
                <source>Neuropediatrics</source>
                <volume>33</volume>
                <fpage>27</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">11930273</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.romano.2009.287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Romano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bajolle</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colomb</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Barac&#x000e9;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vouhe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuillaumier-Barrot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupr&#x000e9;</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Keyzer</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia).</article-title>
                <source>J Med Genet.</source>
                <volume>46</volume>
                <fpage>287</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19357119</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.sanznebot.2007.1949">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sanz-Nebot</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balaguer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benavente</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neusub</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbosa</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Characterization of transferrin glycoforms in human serum by CE-UV and CE-ESI-MS.</article-title>
                <source>Electrophoresis</source>
                <volume>28</volume>
                <fpage>1949</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">17523137</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.schade_van_westrum.2006.115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schade van Westrum</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nederkoorn</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuurman</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vulsma</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duran</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poll-The</surname>
                    <given-names>BT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Skeletal dysplasia and myelopathy in congenital disorder of glycosylation type IA.</article-title>
                <source>J Pediatr</source>
                <volume>148</volume>
                <fpage>115</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16423609</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.schoffer.2006.869">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schoffer</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Sullivan</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGill</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Congenital disorder of glycosylation type Ia presenting as early-onset cerebellar ataxia in an adult.</article-title>
                <source>Mov Disord.</source>
                <volume>21</volume>
                <fpage>869</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">16482534</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.schollen.2007.408">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schollen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keldermans</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulquier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briones</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Valverde</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adamowicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronicka</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.</article-title>
                <source>Mol Genet Metab</source>
                <volume>90</volume>
                <fpage>408</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">17307006</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.schollen.2004.877">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schollen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjaergaard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinsson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuillaumier-Barrot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunoe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keldermans</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>877</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">15520415</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.schollen.1998.157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schollen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pardon</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heykants</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renard</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doggett</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callen</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassiman</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene.</article-title>
                <source>Hum Mol Genet</source>
                <volume>7</volume>
                <fpage>157</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">9425221</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.sinha.2009.2591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sinha</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horsfield</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komaromy</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Booth</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Champion</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Congenital disorders of glycosylation: a rare cause of nephrotic syndrome.</article-title>
                <source>Nephrol Dial Transplant</source>
                <volume>24</volume>
                <fpage>2591</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19474279</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.shanti.2009.s241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shanti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silink</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhattacharya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fietz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christodoulou</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Congenital disorder of glycosylation type Ia: Heterogeneity I the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency.</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>32</volume>
                <supplement>Suppl 1</supplement>
                <fpage>S241</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">19396570</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.stefanits.2014.546">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stefanits</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konstantopoulou</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuess</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milenkovic</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matula</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Initial diagnosis of the congenital disorder of glycosylation PMM2-CDG (CDG1a) in a 4-year-old girl after neurosurgical intervention for cerebral hemorrhage.</article-title>
                <source>J Neurosurg Pediatr.</source>
                <volume>14</volume>
                <fpage>546</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25192236</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.stibler.1994.71">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stibler</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skovby</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Failure to diagnose carbohydrate-deficient glycoprotein syndrome prenatally.</article-title>
                <source>Pediatr Neurol</source>
                <volume>11</volume>
                <fpage>71</fpage>
                <pub-id pub-id-type="pmid">7527215</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.stibler.1994.552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stibler</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blennow</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kristiansson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindehammer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagberg</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>57</volume>
                <fpage>552</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8201322</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.str_m.1993.253">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Str&#x000f8;m</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stromme</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westvik</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedersen</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Renal cysts in the carbohydrate-deficient glycoprotein syndrome.</article-title>
                <source>Pediatr Nephrol</source>
                <volume>7</volume>
                <fpage>253</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8518092</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.tayebi.2002.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tayebi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>DQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orvisky</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McReynolds</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidransky</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A deletion-insertion mutation in the phosphomannomutase 2 gene in an African American patient with congenital disorders of glycosylation-Ia.</article-title>
                <source>Am J Med Genet</source>
                <volume>108</volume>
                <fpage>241</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11891694</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.thompson.2013.1039">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyons</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell-Eggitt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liasis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;gle</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;newald</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG.</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>36</volume>
                <fpage>1039</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">23430200</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.truin.2008.481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Truin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mailys</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefeber</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykut-Cegielska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adamowicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoppenreijs</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sengers</surname>
                    <given-names>RCA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Pericardial and abdominal fluid accumulation in congenital disorder of glycosylation type Ia.</article-title>
                <source>Mol Genet Metab</source>
                <volume>94</volume>
                <fpage>481</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18571450</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.van_de_kamp.2007.277">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van de Kamp</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefeber</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruijter</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steggerda</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>den Hollander</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willems</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poorthuis</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Congenital disorders of glycosylation type Ia presenting with hydrops fetalis.</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>277</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">17158594</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.van_schaftingen.1995.318">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Schaftingen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.</article-title>
                <source>FEBS Lett</source>
                <volume>377</volume>
                <fpage>318</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">8549746</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.varki.1993.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varki</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Biological roles of oligosaccharides: all of the theories are correct.</article-title>
                <source>Glycobiology</source>
                <volume>3</volume>
                <fpage>97</fpage>
                <lpage>130</lpage>
                <pub-id pub-id-type="pmid">8490246</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.verstegen.2012.113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verstegen</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodore</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Klerk</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Lymphatic edema in congenital disorders of glycosylation.</article-title>
                <source>JIMD Rep.</source>
                <year>2012</year>
                <volume>4</volume>
                <fpage>113</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23430905</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.westphal.2001.71">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Westphal</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCracken</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeze</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Functional analysis of novel mutations in a congenital disorder of glycosylation Ia patient with mixed Asian ancestry.</article-title>
                <source>Mol Genet Metab</source>
                <volume>73</volume>
                <fpage>71</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11350185</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.westphal.2002.599">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Westphal</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjaergaard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schollen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martens</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grunewald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeze</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>11</volume>
                <fpage>599</fpage>
                <lpage>604</lpage>
                <pub-id pub-id-type="pmid">11875054</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.wolthuis.2014.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolthuis</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassiman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefeber</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylation.</article-title>
                <source>Expert Rev Mol Diagn.</source>
                <volume>14</volume>
                <fpage>217</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">24524732</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.yoshida.2001.717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manya</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taniguchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kano</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inazu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsuhashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeuchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topaloglu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Endo</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.</article-title>
                <source>Dev Cell</source>
                <volume>1</volume>
                <fpage>717</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">11709191</pub-id>
              </element-citation>
            </ref>
            <ref id="cdg-1a.REF.z_hlsdorf.2015.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Z&#x000fc;hlsdorf</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rust</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reunert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DuChesne</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;neberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquardt</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Transferrin variants: pitfalls in the diagnostics of congenital disorders of glycosylation.</article-title>
                <source>Clin Biochem.</source>
                <volume>48</volume>
                <fpage>11</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">25305627</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="cdg-1a.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="cdg-1a.Suggested_Reading.reflist0">
            <ref id="cdg-1a.REF.jaeken">
              <mixed-citation publication-type="web">Jaeken J, Matthijs G, Carchon H, Van Schaftingen E. Defects of N-glycan synthesis. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> Chap 74. McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cdg-1a.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cdg-1a.Author_Notes">
          <title>Author Notes</title>
          <p>Susan Sparks is a board-certified pediatrician, clinical geneticist, and clinical biochemical geneticist. After completion of her genetics and biochemical genetics fellowship at the National Institutes of Health, she joined the faculty at Children&#x02019;s National Medical Center in Washington, DC, and subsequently the faculty at Levine Children&#x02019;s Hospital at Carolinas Medical Center in Charlotte, NC. She received her MD and PhD in molecular biology and pharmacology from the Chicago Medical School in 1999 and 1997 respectively. She is currently a medical director for genetic diseases with Sanofi Genzyme.</p>
          <p>Donna Krasnewich is a board-certified clinical biochemical geneticist and pediatrician. She trained at Wayne State University School of Medicine in Detroit, Michigan, and received her MD and PhD in pharmacology in 1986. After completing her fellowship in genetics at the National Institutes of Health (NIH), she joined the faculty of the National Human Genome Research Institutes (NHGRI) at NIH where she saw children with developmental delay and congenital disorders of glycosylation. In 2009 she moved to the National Institute of General Medical Sciences where she is a Program Director in the Division of Genetics.</p>
        </sec>
        <sec id="cdg-1a.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>29 October 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>21 April 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 July 2008 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>15 August 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>27 February 2004 (dk) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="cdg-1a.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>N-linked glycans are synthesized by adding individual charged sugars in a specific order to the growing multi-sugar structure, or oligosaccharide. The enzyme PMM2 is required for synthesis of one of these charged sugars, mannose-1-phosphate (man-1-P) from mannose-6-phosphate (man-6-P). Without adequate pools of Man-1P (as a result of decreased activity of PMM2), synthesis of complete N-linked glycans will be affected. The early steps of this complex multistep pathway occur in the endoplasmic reticulum, followed by completion of the synthesis after the growing structure is transferred to the Golgi.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cdg-1a-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
